Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 28 August 2026.
Announcements
6,191
Total raised
£161B
disclosed amounts
This month
£621M
raised so far
The Manchester-based messaging platform raised the capital from backers including GP Bullhound and the Angel CoFund to accelerate expansion.
"Our mission is to make it easier for consumers to connect with service providers in regulated industries like Financial Services. Our clients are using Nivo to deliver simpler mobile experiences, which reduce effort and empower customers. This means everyone saves time, costs go down and satisfaction goes up."
The funding round was led by Lev Leviev of LVL1 Group to support global expansion and product development.
"This is a pivotal moment in the evolution of Fnatic"
The investment includes £750k from NPIF - Mercia Equity Finance alongside contributions from private backers.
"We’re pleased to receive support from the Northern Powerhouse Investment Fund as well as adding some great new non-executive expertise to our board. The funding will allow us to invest further in product development to scale our matchmaking platform and our Discover product, in line with our vision of connecting university research with companies around the world to positively impact on society."
The seed follow-on round was led by Hambro Perks and backed by the founders of Thomsons Online Benefits.
"Moving jobs or hiring a new employee should be the most exciting part of your professional life – it’s the start of a new journey and new opportunities. Unfortunately, most of us have been left jaded by slow, monotonous and demoralising recruitment processes and agencies,"
The grant will fund an online platform providing researchers with access to AI models and algorithms.
"This partnership and funding clearly indicate the importance and value of artificial intelligence as a new approach to support UK SMEs and reinvigorate drug discovery. Our aim is to help deliver a platform which is of high value to UK SMEs to advance their own drug discovery projects faster and more efficiently by accessing otherwise inaccessible, complex technical expertise"
